MicroRNAs and cancer: A meeting summary of the eponymous Keystone Conference

4Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This report summarizes the information presented at the 2009 Keystone Conference on MicroRNAs and Cancer, held in Keystone, Colorado, USA, June 10th to 15th 2009. Soon after microRNnAs (miRNnAs) emerged as an abundant new class of non-coding RNAs (ncRNAs), evidence started to mount supporting important roles for these regulatory RNAs in human health and disease. Mis-regulation of specific miRNA pathways has been linked to diverse cancers. The recent Keystone meeting highlighted progress in understanding the role of miRNAs in normal development and oncogenesis. Recurring themes included the complexities associated with miRNA biogenesis, target recognition, elucidation of genetic networks where miRNAs play pivotal roles often within feedback loops, and the promise of small RNAs as diagnostics and therapeutics in combating cancer. © 2010 Landes Bioscience.

Cite

CITATION STYLE

APA

Godshalk, S. E., Melnik-Martinez, K. V., Pasquinelli, A., & Slack, F. J. (2010). MicroRNAs and cancer: A meeting summary of the eponymous Keystone Conference. Epigenetics, 5(2), 164–168. https://doi.org/10.4161/epi.5.2.11162

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free